Marimed (MRMD) Receivables - Other (2016 - 2024)
Marimed (MRMD) has disclosed Receivables - Other for 12 consecutive years, with $302000.0 as the latest value for Q3 2024.
- Quarterly Receivables - Other rose 247.13% to $302000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $302000.0 through Sep 2024, up 247.13% year-over-year, with the annual reading at $105000.0 for FY2023, 262.07% up from the prior year.
- Receivables - Other for Q3 2024 was $302000.0 at Marimed, up from $233000.0 in the prior quarter.
- The five-year high for Receivables - Other was $29.0 million in Q4 2020, with the low at $9937.0 in Q3 2020.
- Average Receivables - Other over 5 years is $2.9 million, with a median of $143000.0 recorded in 2023.
- The sharpest move saw Receivables - Other tumbled 99.69% in 2020, then surged 565.71% in 2024.
- Over 5 years, Receivables - Other stood at $29.0 million in 2020, then crashed by 82.76% to $5.0 million in 2021, then plummeted by 99.42% to $29000.0 in 2022, then skyrocketed by 262.07% to $105000.0 in 2023, then soared by 187.62% to $302000.0 in 2024.
- According to Business Quant data, Receivables - Other over the past three periods came in at $302000.0, $233000.0, and $181000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.